WallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Earnings & Revenue

TAK past earnings growth

How has TAK's earnings growth performed historically?
Company
-79.34%
Industry
19.14%
Market
76.74%
TAK's earnings have grown slower (-92.88% per year) than the US Drug Manufacturers - Specialty & Generic industry average (4.33%)
Performance
TAK's earnings have grown slower (-92.88% per year) than the US market average (21.24%)
Performance

TAK past revenue growth

How has TAK's revenue growth performed historically?
Company
59.98%
Industry
35.51%
Market
27.97%
TAK's revenue has grown faster (98.34% per year) than the US Drug Manufacturers - Specialty & Generic industry average (38.96%)
Performance
TAK's revenue has grown faster (98.34% per year) than the US market average (16.83%)
Performance

TAK earnings and revenue history

Current Revenue
$30.5B
Current Earnings
$410.0M
Current Profit Margin
1.3%

TAK Return on equity

Current Company
0.9%
Current Industry
20.7%
Current Market
-160.8%
TAK's Return on Equity (0.9%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

TAK Return on assets

Current Company
0.3%
Current Industry
-7.9%
Current Market
6.8%
TAK is generating higher Return on Assets (0.3%) than the US Drug Manufacturers - Specialty & Generic industry average (-0.8%)
Performance

TAK Return on capital employed

Current Company
0.98%
Current Industry
6.5%

Takeda Pharmaceutical Ltd Earnings & Revenue FAQ

What was TAK's earnings growth in the past year?

As of Q2 2021, Takeda Pharmaceutical Ltd's earnings has grown -79.34% year over year. This is 98.49 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 19.14%. Takeda Pharmaceutical Ltd's earnings in the past year totalled $413.85 million.

What was TAK's revenue growth in the past year?

As of Q2 2021, Takeda Pharmaceutical Ltd's revenue has grown 59.98% year over year. This is 24.47 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 35.51%. Takeda Pharmaceutical Ltd's revenue in the past year totalled $30.79 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.